1. Sahu S, Hemlata , Verma A. Adverse events related to blood transfusion. Indian J Anaesth. 2014; 58:543–551. PMID:
25535415.
Article
2. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg. 2009; 108:759–769. PMID:
19224780.
Article
3. Kato H, Nakayama T, Uruma M, Okuyama Y, Handa M, Tomiyama Y, et al. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history. Vox Sang. 2015; 108:243–250. PMID:
25536173.
Article
4. Tinegate H, Birchall J, Gray A, Haggas R, Massey E, Norfolk D, et al. Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force. Br J Haematol. 2012; 159:143–153. PMID:
22928769.
Article
5. Fry JL, Arnold DM, Clase CM, Crowther MA, Holbrook AM, Traore AN, et al. Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion. 2010; 50:1722–1730. PMID:
20345566.
Article
6. Mazzei CA, Popovsky MA, Kopko PM. Noninfectious complications of blood transfusion. In : Mark K, Brenda J, Christophjer D, Connie M, editors. Technical manual. 18th ed. Bethesda, MD: American Association of Blood Banks;2014. p. 665–696.
7. Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention Atlanta GA, USA. National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol c.2.1.3. Updated on August 2014.
http://www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf.
8. Yeh SP, Chang CW, Chen JC, Yeh WC, Chen PC, Chuang SJ, et al. A well-designed online transfusion reaction reporting system improves the estimation of transfusion reaction incidence and quality of care in transfusion practice. Am J Clin Pathol. 2011; 136:842–847. PMID:
22095368.
Article
9. de Vries RR, Faber JC, Strengers PF. Board of the International Haemovigilance Network. Haemovigilance: an effective tool for improving transfusion practice. Vox Sang. 2011; 100:60–67. PMID:
21175656.
Article
10. Uhlmann EJ, Isgriggs E, Wallhermfechtel M, Goodnough LT. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion. 2001; 41:997–1000. PMID:
11493730.
Article
11. Yazer MH, Podlosky L, Clarke G, Nahirniak SM. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion. 2004; 44:10–15. PMID:
14692961.
Article
12. Bilgin YM, van de Watering LM, Brand A. Clinical effects of leucoreduction of blood transfusions. Neth J Med. 2011; 69:441–450. PMID:
22058263.
13. Harvey AR, Basavaraju SV, Chung KW, Kuehnert MJ. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012. Transfusion. 2015; 55:709–718.
Article
14. Wang RR, Triulzi DJ, Qu L. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets. Am J Clin Pathol. 2012; 138:255–259. PMID:
22904138.
Article
15. Paglino JC, Pomper GJ, Fisch GS, Champion MH, Snyder EL. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion. 2004; 44:16–24. PMID:
14692962.
Article
16. Dasararaju R, Marques MB. Adverse effects of transfusion. Cancer Control. 2015; 22:16–25. PMID:
25504275.
Article